301 related articles for article (PubMed ID: 17965749)
21. Intermedin/Adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells.
Taylor MM; Bagley SL; Samson WK
Endocrinology; 2006 Feb; 147(2):859-64. PubMed ID: 16269457
[TBL] [Abstract][Full Text] [Related]
22. Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes.
Bell D; Zhao Y; McCoy FP; Devine A; McDermott BJ
Cell Physiol Biochem; 2008; 21(5-6):409-20. PubMed ID: 18453748
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency.
Bell D; Zhao Y; McCoy FP; Devine AB; McDermott BJ
Cell Physiol Biochem; 2007; 20(5):269-82. PubMed ID: 17762156
[TBL] [Abstract][Full Text] [Related]
24. Upregulated expression of intermedin and its receptor in the myocardium and aorta in spontaneously hypertensive rats.
Zeng Q; Yuan Y; Wang X; Wu HM; Fan L; Qi YF; Tang CS; Cai Y; Pan CS
Peptides; 2009 Feb; 30(2):391-9. PubMed ID: 19041918
[TBL] [Abstract][Full Text] [Related]
25. Intermedin in the paraventricular nucleus attenuates cardiac sympathetic afferent reflex in chronic heart failure rats.
Gan XB; Sun HJ; Chen D; Zhang LL; Zhou H; Chen LY; Zhou YB
PLoS One; 2014; 9(4):e94234. PubMed ID: 24709972
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2.
Pan CS; Yang JH; Cai DY; Zhao J; Gerns H; Yang J; Chang JK; Tang CS; Qi YF
Peptides; 2005 Sep; 26(9):1640-6. PubMed ID: 16112404
[TBL] [Abstract][Full Text] [Related]
27. Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components.
Bell D; Zhao YY; Devine AB; McDermott BJ
Cell Physiol Biochem; 2008; 21(1-3):203-14. PubMed ID: 18209487
[TBL] [Abstract][Full Text] [Related]
28. Expression of adrenomedullin 2/intermedin, a possible reno-protective peptide, is decreased in the kidneys of rats with hypertension or renal failure.
Hirose T; Totsune K; Mori N; Mori T; Morimoto R; Metoki H; Asayama K; Kikuya M; Ohkubo T; Kohzuki M; Takahashi K; Imai Y
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F128-34. PubMed ID: 20462970
[TBL] [Abstract][Full Text] [Related]
29. Stress hormone secretion is altered by central administration of intermedin/adrenomedullin-2.
Taylor MM; Samson WK
Brain Res; 2005 May; 1045(1-2):199-205. PubMed ID: 15910778
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts.
Yang JH; Qi YF; Jia YX; Pan CS; Zhao J; Yang J; Chang JK; Tang CS
Peptides; 2005 Mar; 26(3):501-7. PubMed ID: 15652657
[TBL] [Abstract][Full Text] [Related]
31. Spatial expression of components of a calcitonin receptor-like receptor (CRL) signalling system (CRL, calcitonin gene-related peptide, adrenomedullin, adrenomedullin-2/intermedin) in mouse and human heart valves.
Pfeil U; Bharathala S; Murtaza G; Mermer P; Papadakis T; Boening A; Kummer W
Cell Tissue Res; 2016 Dec; 366(3):587-599. PubMed ID: 27553639
[TBL] [Abstract][Full Text] [Related]
32. Intermedin 1-53 in central nervous system elevates arterial blood pressure in rats.
Ren YS; Yang JH; Zhang J; Pan CS; Yang J; Zhao J; Pang YZ; Tang CS; Qi YF
Peptides; 2006 Jan; 27(1):74-9. PubMed ID: 16023765
[TBL] [Abstract][Full Text] [Related]
33. Effects of intermedin(1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts.
Yang JH; Jia YX; Pan CS; Zhao J; Ouyang M; Yang J; Chang JK; Tang CS; Qi YF
Biochem Biophys Res Commun; 2005 Feb; 327(3):713-9. PubMed ID: 15649405
[TBL] [Abstract][Full Text] [Related]
34. Intermedin elicits a negative inotropic effect in rat papillary muscles mediated by endothelial-derived nitric oxide.
Pires AL; Pinho M; Sena CM; Seica R; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2012 Mar; 302(5):H1131-7. PubMed ID: 22227127
[TBL] [Abstract][Full Text] [Related]
35. Adrenomedullin - Current perspective on a peptide hormone with significant therapeutic potential.
Fischer JP; Els-Heindl S; Beck-Sickinger AG
Peptides; 2020 Sep; 131():170347. PubMed ID: 32569606
[TBL] [Abstract][Full Text] [Related]
36. Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats.
Zhou YB; Sun HJ; Chen D; Liu TY; Han Y; Wang JJ; Tang CS; Kang YM; Zhu GQ
Hypertension; 2014 Feb; 63(2):330-7. PubMed ID: 24218431
[TBL] [Abstract][Full Text] [Related]
37. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
Moad HE; Pioszak AA
Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
[TBL] [Abstract][Full Text] [Related]
38. Effect of calcitonin gene-related peptide (CGRP), adrenomedullin and adrenomedullin-2/intermedin on food intake in goldfish (Carassius auratus).
Martínez-Alvarez RM; Volkoff H; Muñoz-Cueto JA; Delgado MJ
Peptides; 2009 Apr; 30(4):803-7. PubMed ID: 19150637
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin Peptide Family Members Are Differentially Regulated by LPS and Inhibit Functions of Rat Alveolar NR8383 Macrophages.
Soultanova A; Mikulski Z; Pfeil U; Grau V; Kummer W
PLoS One; 2016; 11(10):e0163483. PubMed ID: 27737007
[TBL] [Abstract][Full Text] [Related]
40. Expression of adrenomedullin2/intermedin in human brain, heart, and kidney.
Morimoto R; Satoh F; Murakami O; Totsune K; Suzuki T; Sasano H; Ito S; Takahashi K
Peptides; 2007 May; 28(5):1095-103. PubMed ID: 17346853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
